The principle remit of the group is to prioritise and coordinate the development of reference preparations for clinically-relevant pathogens, but also to provide a forum to discuss assay performance and technology issues. Participation is encouraged from clinical laboratories, manufacturers of diagnostic assays and quality control reagents, providers of external quality assessment schemes, and regulatory and public health authorities.